The FKBP5 gene, a glucocorticoid receptor (GR)-regulating co-chaperone of stress proteins, is of special interest because of its role in hypothalamic-pituitary-adrenal (HPA)-axis regulation. However, studies finding a genetic relationship between posttraumatic stress disorder (PTSD) and the FKBP5 gene have failed to distinguish between the development and persistence of PTSD, thereby limiting the prognostic usefulness of such a finding. The present study sought to longitudinally explore this question by examining the association between four single-nucleotide polymorphisms (SNPs) in the FKBP5 gene (rs3800373, rs9470080, rs1360780, and rs9296158), the persistence of PTSD (severity and diagnostic status), and memory performance among twenty-two treatment-seekers diagnosed with acute PTSD. Results showed that the four SNPs significantly interacted with improvement in PTSD symptoms as well as PTSD diagnostic status. Individuals homozygous for the dominant allele and having experienced higher levels of peritraumatic responses subsequently showed more memory dysfunction. The results of this study suggest that SNPs in the FKBP5 gene are associated with symptom persistence and memory dysfunction in acute PTSD.
References
[1]
Schnurr, P.P.; Lunney, C.A.; Sengupta, A. Risk factors for the development versus maintenance of posttraumatic stress disorder. J. Trauma. Stress 2004, 17, 85–95, doi:10.1023/B:JOTS.0000022614.21794.f4.
[2]
Breslau, N.; Kessler, R.C.; Chilcoat, H.D.; Schultz, L.R.; Davis, G.C.; Andreski, P. Trauma and posttraumatic stress disorder in the community: The 1996 detroit area survey of trauma. Arch. Gen. Psychiatry 1998, 55, 626–632, doi:10.1001/archpsyc.55.7.626.
Brunet, A.; Corbo, V.; Sergerie, K. Développement et rémission des psychotraumatismes: éléments d’une théorie neurocognitive. Stress Trauma. 2006, 6, 141–160.
[5]
Thomas, E.; Saumier, D.; Brunet, A. Peritraumatic distress and the course of posttraumatic stress disorder symptoms: A meta-analysis. Can. J. Psychiatry. 2012, 57, 122–129. 22340152
[6]
Koenen, K.C.; Nugent, N.R.; Amstadter, A.B. Gene-environment interaction in posttraumatic stress disorder: Review, strategy and new directions for future research. Eur. Arch. Psychiatry Clin. Neurosci. 2008, 258, 82–96, doi:10.1007/s00406-007-0787-2.
[7]
Gottesman, I.I.; Gould, T.D. The endophenotype concept in psychiatry: Etymology and strategic intentions. Am. J. Psychiatry 2003, 160, 636–645, doi:10.1176/appi.ajp.160.4.636.
[8]
Binder, E.B. The role of FKBP5, a co-chaperone of the glucocorticoid receptor in the pathogenesis and therapy of affective and anxiety disorders. Psychoneuroendocrinology 2009, 34 Suppl 1, S186–S195, doi:10.1016/j.psyneuen.2009.05.021.
Van Praag, H.M. The cognitive paradox in posttraumatic stress disorder: A hypothesis. Prog. Neuropsychopharmacol. Biol. Psychiatry 2004, 28, 923–935, doi:10.1016/j.pnpbp.2004.05.011.
[11]
Yang, Y.L.; Chao, P.K.; Lu, K.T. Systemic and intra-amygdala administration of glucocorticoid agonist and antagonist modulate extinction of conditioned fear. Neuropsychopharmacology 2006, 31, 912–924, doi:10.1038/sj.npp.1300899.
[12]
Koenen, K.C.; Saxe, G.; Purcell, S.; Smoller, J.W.; Bartholomew, D.; Miller, A.; Hall, E.; Kaplow, J.; Bosquet, M.; Moulton, S.; et al. Polymorphisms in FKBP5 are associated with peritraumatic dissociation in medically injured children. Mol. Psychiatry 2005, 10, 1058–1059, doi:10.1038/sj.mp.4001727.
[13]
Binder, E.B.; Bradley, R.G.; Liu, W.; Epstein, M.P.; Deveau, T.C.; Mercer, K.B.; Tang, Y.; Gillespie, C.F.; Heim, C.M.; Nemeroff, C.B.; et al. Asociation of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults. JAMA 2008, 299, 1291–1305, doi:10.1001/jama.299.11.1291. 18349090
[14]
Mehta, D.; Gonik, M.; Klengel, T.; Rex-Haffner, M.; Menke, A.; Rubel, J.; Mercer, K.B.; Pütz, B.; Bradley, B.; Holsboer, F.; et al. Using polymorphisms in FKBP5 to define biologically distinct subtypes of posttraumatic stress disorder: Evidence from endocrine and gene expression studies. Arch. Gen. Psychiatry 2011, 68, 901–910, doi:10.1001/archgenpsychiatry.2011.50.
[15]
Xie, P.; Kranzler, H.R.; Poling, J.; Stein, M.B.; Anton, R.F.; Farrer, L.A.; Gelernter, J. Interaction of FKBP5 with childhood adversity on risk for post-traumatic stress disorder. Neuropsychopharmacology 2010, 35, 1684–1692. 20393453
[16]
Sarapas, C.; Cai, G.; Bierer, L.M.; Golier, J.A.; Galea, S.; Ising, M.; Rein, T.; Schmeidler, J.; Müller-Myhsok, B.; Uhr, M.; et al. Genetic markers for PTSD risk and resilience among survivors of the World Trade Center attacks. Dis Markers 2011, 30, 101–110. 21508514
[17]
Association, A.P. Diagnostic and Statistical Manual of Mental Disorders, 4th ed.; Wikipedia: Washington, DC, USA, 2000.
[18]
Brunet, A.; Weiss, D.S.; Metzler, T.J.; Best, S.R.; Neylan, T.C.; Rogers, C.; Fagan, J.; Marmar, C.R. The peritraumatic distress inventory: A proposed measure of PTSD criterion A2. Am. J. Psychiatry 2001, 158, 1480–1485, doi:10.1176/appi.ajp.158.9.1480.
[19]
Jehel, L.; Brunet, A.; Paterniti, S.; Guelfi, J.D. Validation of the peritraumatic distress inventory’s French translation. Can. J. Psychiatry 2005, 50, 67–71. 15754668
[20]
Marmar, C.R.; Weiss, D.S.; Metzler, T.J. The Peritraumatic Dissociative Experiences Questionnaire; Wilson, J.P., Keane, T.M., Eds.; Guilford Press: New York, NY, USA, 1997.
[21]
Birmes, P.; Brunet, A.; Benoit, M.; Defer, S.; Hatton, L.; Sztulman, H.; Schmitt, L. Validation of the peritraumatic dissociative experiences questionnaire self-report version in two samples of French-speaking individuals exposed to trauma. Eur. Psychiatry 2005, 20, 145–151, doi:10.1016/j.eurpsy.2004.06.033.
[22]
Blake, D.D.; Weathers, F.W.; Nagy, L.M.; Kaloupek, D.G.; Gusman, F.D.; Charney, D.S.; Keane, T.M. The development of a clinician-administered PTSD scale. J. Trauma. Stress 1995, 8, 75–90, doi:10.1002/jts.2490080106.
[23]
Weathers, F.W.; Ruscio, A.M.; Keane, T.M. Psychometric properties of nine scoring rules for the clinician-administered posttraumatic stress disorder scale. Psychol. Assess. 1999, 11, 124–133, doi:10.1037/1040-3590.11.2.124.
[24]
Sheehan, D.V.; Lecrubier, Y.; Sheehan, K.H.; Amorim, P.; Janavs, J.; Weiller, E.; Hergueta, T.; Baker, R.; Dunbar, G.C. The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatry 1998, 59 Quiz 4-57, 22–33. 9881538
[25]
Beck, A.T.; Ward, C.H.; Mendelson, M.; Mock, J.; Erbaugh, J. An inventory for measuring depression. Arch. Gen. Psychiatry 1961, 4, 561–571, doi:10.1001/archpsyc.1961.01710120031004.
[26]
Vakil, E.; Blachstein, H. Rey auditory-verbal learning test: Structure analysis. J. Clin. Psychol. 1993, 49, 883–890, doi:10.1002/1097-4679(199311)49:6<883::AID-JCLP2270490616>3.0.CO;2-6.
[27]
Spreen, O.; Sherman, E.M.S.; Strauss, E. A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary, 3rd ed.; Oxford University Press: New York, NY, USA, 2006.
[28]
Madjan, A.; Sziklas, V.; Jones-Gotman, M. Performance of healthy subjects and patients with resection from the anterior temporal lobe on matched tests of verbal and visuoperceptual learning. J. Clin. Exp. Neuropsychol. 1996, 18, 416–430, doi:10.1080/01688639608408998.
[29]
David, A.C.; Akerib, V.; Gaston, L.; Brunet, A. Consistency of retrospective reports of peritraumatic responses and their relation to PTSD diagnostic status. J. Trauma. Stress 2010, 23, 599–605, doi:10.1002/jts.20566.
